Navigation Links
New Gas Clean Filter Technology From Varian, Inc. Reduces Contamination in GC, ICP and GC/MS
Date:3/11/2009

PALO ALTO, Calif., March 11 /PRNewswire-FirstCall/ -- Varian, Inc. (Nasdaq: VARI) announces today three significant advances to its Gas Clean Filter System, for delivering clean gases for GC (gas chromatography) and GC/MS (gas chromatography/mass spectrometry), LC/MS (liquid chromatography/mass spectroscopy) and ICP (inductively coupled plasma) operations.

New to the Gas Clean family is a carbon dioxide filter that improves the sensitivity of both flame photometric detectors in GC and the CO2 detector in Total Organic Carbon analyzers, helping chemists get better results from their instruments.

Also new is the universal high-flow base plate that handles flow rates up to 20 L/min, compatible with all Varian filters. The range of applications is expanded and includes the use with collision gas to prevent mass interferences in LC/MS, and for argon supply filtering in ICP-OES and ICP-MS.

Improvements to the absorbent materials in both the GC/MS and moisture filters allow them to stabilize more quickly to reduce downtime and improve productivity.

In gas chromatography, the filters are positioned in the gas line between the compressed gas cylinders and the instrument. Reducing contamination in the gas reduces the risk of column damage. With the filters in place, chemists can save money by using less expensive, lower grade gases and still get the results they require. For example, the filters provide immediate savings of up to 50% on helium, with no loss in analytical quality.

Using Gas Clean Filters with Varian's FactorFour(TM) ultra low-bleed columns and new GC instruments creates the best combination for optimal GC and GC/MS performance.

"Enhancing the Gas Clean Filter System provides a broader choice of options for analytical chemists to match their specific requirements," said Martin O'Donoghue, Senior Vice President, Scientific Instruments, Varian, Inc. "As part of a complete solution for our GC, GC/MS and ICP customers, the improved filters reduce costs while offering equivalent or improved data quality."

For more technical information about Varian's GC and Mass Spectrometry instrumentation and consumables, please visit http://www.varianinc.com/products/

Varian, Inc. is a leading worldwide supplier of scientific instruments and vacuum technologies for life science and industrial applications. The company provides complete solutions, including instruments, vacuum products, laboratory consumable supplies, software, training and support through its global distribution and support systems. Varian, Inc. employs approximately 3,700 people worldwide and operates manufacturing facilities in North America, Europe and Asia Pacific. Varian, Inc. had fiscal year 2008 sales of $1 billion, and its common stock is traded on the NASDAQ Global Select Market under the symbol, "VARI." Further information is available on the company's Web site: http://www.varianinc.com.

    For More Information, Contact:
    Press Relations
    Varian, Inc.
    925.942.4703
    pr@varianinc.com


'/>"/>
SOURCE Varian, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. White Paper Details How DNA Sequencing Services Can Prevent Cleanroom Shutdowns at Medical Device and Pharmaceutical Manufacturers
2. Zymetis Inc. Named Top 50 Cleantech/Greentech Company
3. TechConnect World Publishes Conference Agenda Featuring More than 2,700 Presentations Addressing Nano, Bio and Clean Technologies
4. Pitt researchers create nontoxic clean-up method for potentially toxic nano materials
5. ASP Announces Availability of EVOTECH(TM) Endoscope Cleaner and Reprocessor - First Commercially Available System to Eliminate Manual Cleaning of Endoscopes
6. DAZ Systems, Inc. Thrives in the Clean Energy Industry
7. Photo-catalytic, self cleaning coating for building exteriors
8. White Paper Details How DNA Sequencing Services Can Prevent Cleanroom Shutdowns at Medical Device and Pharmaceutical Manufacturers
9. China Clean Energy Resumes Biodiesel Production After Temporary Halt
10. San Diego universities, government and industry rally around local Clean-Tech cluster
11. The Elmasonic S Ultrasonic Cleaner: Designed for the Scientific Laboratory
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... -- The Board of Directors of the Pittsburgh Life ... only pure life sciences investment firm, today announced ... plan developed by the Nominating and Governance Committee over ... F. Jordan is selected to serve as President ... , who is elected to the position of Executive ...
(Date:12/8/2016)... 2016  OncoSec Medical Incorporated ("OncoSec") (NASDAQ: ... cancer immunotherapies, today announced financial results for the ... are delivering on our commitment to address an ... We are pleased with the early clinical response ... we are focused on advancing our lead program ...
(Date:12/8/2016)...  Biotheranostics today announced that new data will ... Cancer Index (BCI) in identifying which patients with ... for disease recurrence and might benefit from extended ... advancing the understanding of the value of BCI ... inform decisions related to patient treatment. These data ...
(Date:12/8/2016)... Washington, USA, and CARDIFF, UK (PRWEB) , ... ... ... circuits with very high precision light to control cells — optogenetics — is ... In the current state of the art, spatially patterned light projected via free-space ...
Breaking Biology Technology:
(Date:12/2/2016)... , December 1, 2016 ... (Fingerprint, Voice), Future Technology (Iris Recognition System), Vehicle ... - Global Forecast to 2021", published by MarketsandMarkets, ... Million in 2016, and is projected to grow ... CAGR of 14.06%.      (Logo: http://photos.prnewswire.com/prnh/20160303/792302) ...
(Date:11/30/2016)... 30, 2016 Not many of us realize that we spend ? of ... we need to do it well. Inadequate sleep levels have been found to lead ... diabetes, and even cancer. Maybe now is the best time to rethink ... them to manage their sleep quality? Continue Reading ... ...
(Date:11/29/2016)... BioDirection, a privately held medical device company developing novel ... concussion and other traumatic brain injury (TBI), announced today ... the U.S. Food and Drug Administration (FDA) to review ... meeting company representatives reviewed plans for clinical development of ... a planned pilot trial. "We are ...
Breaking Biology News(10 mins):